Mégane Noirfalise
Digital transformation has been spreading throughout industries and pharmaceutical companies are no exception. The development of the recent COVID-19 vaccine is a good exemple of the impact and benefits that digitalization can have on reducing clinical development timelines.
“Analytical platforms allow both an increased visibility in the global clinical plan and an increased efficiency to execute this plan.” - Sébastien Coppe, N-SIDE
Among many other advantages, digitalization not only benefits companies but it also has a positive impact for patients and society at large. With the right tools, manufacturing bottlenecks can be identified and ultimately removed to ensure faster clinical developments timelines.
In this article, you will also discover:
- How a digital solution lead to millions of budget reductions and considerable waste avoidance
- Must-have technologies to optimize the pharma R&D manufacturing and how to implement them
If you are interested to know more about the challenges of digitalization in pharma manufacturing and how companies can use these technologies to optimize their strategy, you can read Sébastien’s full interview here.
This article is taken from Pharmaceutical Manufacturing and Packing Sourcer October 2021, pages 93-95. © Samedan Ltd
Do you want to know more?
